Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLY 1: Daclatasvir, Sofosbuvir, and Ribavirin in Advanced HCV
NCT02032875Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daclatasvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Mar 2014; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02032875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032875.